677 related articles for article (PubMed ID: 7722326)
21. [Eosinophilic granulocytes and their significance in allergic diseases].
Bruijnzeel PL; Rihs S; Betz S
Schweiz Med Wochenschr; 1992 Feb; 122(6):173-80. PubMed ID: 1535993
[TBL] [Abstract][Full Text] [Related]
22. Decreased expression of eosinophil peroxidase and major basic protein messenger RNAs during eosinophil maturation.
Gruart V; Truong MJ; Plumas J; Zandecki M; Kusnierz JP; Prin L; Vinatier D; Capron A; Capron M
Blood; 1992 May; 79(10):2592-7. PubMed ID: 1375105
[TBL] [Abstract][Full Text] [Related]
23. Urinary eosinophil-derived neurotoxin/protein X: a simple method for assessing eosinophil degranulation in vivo.
Cottin V; Deviller P; Tardy F; Cordier JF
J Allergy Clin Immunol; 1998 Jan; 101(1 Pt 1):116-23. PubMed ID: 9449510
[TBL] [Abstract][Full Text] [Related]
24. Ursodeoxycholic acid inhibits eosinophil degranulation in patients with primary biliary cirrhosis.
Yamazaki K; Suzuki K; Nakamura A; Sato S; Lindor KD; Batts KP; Tarara JE; Kephart GM; Kita H; Gleich GJ
Hepatology; 1999 Jul; 30(1):71-8. PubMed ID: 10385641
[TBL] [Abstract][Full Text] [Related]
25. Extracellular deposition of eosinophil and neutrophil granule proteins in the IgE-mediated cutaneous late phase reaction.
Leiferman KM; Fujisawa T; Gray BH; Gleich GJ
Lab Invest; 1990 May; 62(5):579-89. PubMed ID: 2188046
[TBL] [Abstract][Full Text] [Related]
26. Eosinophil major basic protein: first identified natural heparanase-inhibiting protein.
Temkin V; Aingorn H; Puxeddu I; Goldshmidt O; Zcharia E; Gleich GJ; Vlodavsky I; Levi-Schaffer F
J Allergy Clin Immunol; 2004 Apr; 113(4):703-9. PubMed ID: 15100677
[TBL] [Abstract][Full Text] [Related]
27. Effects of eosinophil granule proteins on human corneal epithelial cell viability and morphology.
Trocmé SD; Hallberg CK; Gill KS; Gleich GJ; Tyring SK; Brysk MM
Invest Ophthalmol Vis Sci; 1997 Mar; 38(3):593-9. PubMed ID: 9071212
[TBL] [Abstract][Full Text] [Related]
28. Peripheral blood eosinophils from patients with allergic asthma contain increased intracellular eosinophil-derived neurotoxin.
Sedgwick JB; Vrtis RF; Jansen KJ; Kita H; Bartemes K; Busse WW
J Allergy Clin Immunol; 2004 Sep; 114(3):568-74. PubMed ID: 15356558
[TBL] [Abstract][Full Text] [Related]
29. Distinctive cationic proteins of the human eosinophil granule: major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin.
Ackerman SJ; Loegering DA; Venge P; Olsson I; Harley JB; Fauci AS; Gleich GJ
J Immunol; 1983 Dec; 131(6):2977-82. PubMed ID: 6644025
[TBL] [Abstract][Full Text] [Related]
30. Role of pertussis toxin-sensitive G proteins in stimulus-dependent human eosinophil degranulation.
Kita H; Abu-Ghazaleh RI; Gleich GJ; Abraham RT
J Immunol; 1991 Nov; 147(10):3466-73. PubMed ID: 1719078
[TBL] [Abstract][Full Text] [Related]
31. Ribonuclease activity associated with human eosinophil-derived neurotoxin and eosinophil cationic protein.
Slifman NR; Loegering DA; McKean DJ; Gleich GJ
J Immunol; 1986 Nov; 137(9):2913-7. PubMed ID: 3760576
[TBL] [Abstract][Full Text] [Related]
32. Increased intraluminal release of eosinophil granule proteins EPO, ECP, EPX, and cytokines in ulcerative colitis and proctitis in segmental perfusion.
Carlson M; Raab Y; Peterson C; Hällgren R; Venge P
Am J Gastroenterol; 1999 Jul; 94(7):1876-83. PubMed ID: 10406252
[TBL] [Abstract][Full Text] [Related]
33. Regulatory effect of cytokines on eosinophil degranulation.
Fujisawa T; Abu-Ghazaleh R; Kita H; Sanderson CJ; Gleich GJ
J Immunol; 1990 Jan; 144(2):642-6. PubMed ID: 2104901
[TBL] [Abstract][Full Text] [Related]
34. Mechanisms for eosinophil degranulation; release of the eosinophil cationic protein.
Winqvist I; Olofsson T; Olsson I
Immunology; 1984 Jan; 51(1):1-8. PubMed ID: 6317543
[TBL] [Abstract][Full Text] [Related]
35. The eosinophilic injury to the mucosa of the airways in the pathogenesis of bronchial asthma.
Frigas E; Motojima S; Gleich GJ
Eur Respir J Suppl; 1991 Apr; 13():123s-135s. PubMed ID: 1953909
[TBL] [Abstract][Full Text] [Related]
36. Allergen extracts directly mobilize and activate human eosinophils.
Svensson L; Rudin A; Wennerås C
Eur J Immunol; 2004 Jun; 34(6):1744-51. PubMed ID: 15162445
[TBL] [Abstract][Full Text] [Related]
37. Localization of human eosinophil granule major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin by immunoelectron microscopy.
Peters MS; Rodriguez M; Gleich GJ
Lab Invest; 1986 Jun; 54(6):656-62. PubMed ID: 3520144
[TBL] [Abstract][Full Text] [Related]
38. Comparative toxicity of purified human eosinophil granule proteins for newborn larvae of Trichinella spiralis.
Hamann KJ; Barker RL; Loegering DA; Gleich GJ
J Parasitol; 1987 Jun; 73(3):523-9. PubMed ID: 3598802
[TBL] [Abstract][Full Text] [Related]
39. Cytophilic and cytotoxic properties of human eosinophil peroxidase plus major basic protein.
Samoszuk MK; Petersen A; Gidanian F; Rietveld C
Am J Pathol; 1988 Sep; 132(3):455-60. PubMed ID: 3414778
[TBL] [Abstract][Full Text] [Related]
40. Eosinophil activity in bronchial asthma.
Venge P
Allergy Proc; 1994; 15(3):139-41. PubMed ID: 7926713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
